概括
这项研究引入了一个新的框架,CiMP,通过整合组织学图像和基因组数据来预测癌症存活率. CiMP利用临床分期提示来增强多模式融合,实现最先进的结果.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 医疗成像医学成像
背景情况:
- 组织学和基因组数据对于癌症预后至关重要.
- 整合这些模式在建模高阶相关性和结合临床知识方面带来了挑战.
- 现有的方法往往缺乏有效的多模式融合预后策略.
研究的目的:
- 通过整合全幻灯片图像 (WSIs) 和基因组数据,开发多模式癌症预后的新框架.
- 解决高维数据不平衡和临床知识在癌症生存预测中的不足利用的挑战.
- 提出一个以预后为导向的图像-omics融合方法,利用临床分期信息.
主要方法:
- 建议的临床阶段快速诱导的多式预后 (CiMP) 框架.
- 利用先进的大型语言模型 (LLM) 来从结构化记录中生成临床分期提示.
- 引入了一个组多头自我注意模块用于基因组数据分析.
- 综合 WSIs 和基因组数据用于多模式预后.
主要成果:
- 在五个TCGA数据集上实现了最先进的性能.
- 与以前的多模式预后模型相比,已经证明了优越性.
- 展示了改善的临床解释性和医疗应用的潜力.
结论:
- CiMP有效地整合了组织学图像和基因组数据,以提高癌症存活率预测.
- 该框架通过阶段提示成功地结合了临床知识,克服了先前方法的局限性.
- 拟议的方法对推进个性化癌症医学和临床决策具有重大前景.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Acute Pancreatitis II: Clinical Manifestations and Management
180
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
180
Chronic Pancreatitis II: Collaborative Care
130
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
130


